Related references
Note: Only part of the references are listed.Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas
M. Dolera et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Expression and targeting of transcription factor ATF5 in dog gliomas
D. York et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Molecular signalling pathways in canine gliomas
C. E. Boudreau et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study
Shamik Chakraborty et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles
Alexandros Bouras et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Systematic Review of Brain Tumor Treatment in Dogs
H. Hu et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2015)
Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
Milota Kaluzova et al.
ONCOTARGET (2015)
Convection-Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations
Neil U. Barua et al.
BRAIN PATHOLOGY (2014)
Advances in Diagnostic and Treatment Modalities for Intracranial Tumors
P. J. Dickinson
JOURNAL OF VETERINARY INTERNAL MEDICINE (2014)
The application of magnetic nanoparticles for the treatment of brain tumors
Keon Mahmoudi et al.
FRONTIERS IN CHEMISTRY (2014)
Postmortem Evaluation of 435 Cases of Intracranial Neoplasia in Dogs and Relationship of Neoplasm with Breed, Age, and Body Weight
R. B. Song et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2013)
New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
Waldemar Debinski et al.
PLOS ONE (2013)
Convection-Enhanced Delivery for Targeted Delivery of Antiglioma Agents: The Translational Experience
Jonathan Yun et al.
JOURNAL OF DRUG DELIVERY (2013)
Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
Josef Singer et al.
MOLECULAR IMMUNOLOGY (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
Convection-Enhanced Delivery: From Mechanisms to Clinical Drug Delivery for Diseases of the Central Nervous System
Ryuta SAITO et al.
NEUROLOGIA MEDICO-CHIRURGICA (2012)
Canine Model of Convection-Enhanced Delivery of Cetuximab-Conjugated Iron-Oxide Nanoparticles Monitored With Magnetic Resonance Imaging
Simon Platt et al.
NEUROSURGERY (2012)
Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review)
Xiang Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy
Mamta Wankhede et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Cetuximab in the treatment of patients with colorectal cancer
Christopher R. Garrett et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
MAGNETIC RESONANCE IMAGING FEATURES OF INTRACRANIAL ASTROCYTOMAS AND OLIGODENDROGLIOMAS IN DOGS
Benjamin D. Young et al.
VETERINARY RADIOLOGY & ULTRASOUND (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma
Costas G. Hadjipanayis et al.
CANCER RESEARCH (2010)
Spontaneous canine gliomas: overexpression of EGFR, PDGFRα and IGFBP2 demonstrated by tissue microarray immunophenotyping
Robert J. Higgins et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Poor drug distribution as a possible explanation for the results of the PRECISE trial Clinical article
John H. Sampson et al.
JOURNAL OF NEUROSURGERY (2010)
Canine spontaneous glioma: A translational model system for convection-enhanced delivery
Peter J. Dickinson et al.
NEURO-ONCOLOGY (2010)
Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain
Hao-Li Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
Benedikte Hasselbalch et al.
NEURO-ONCOLOGY (2010)
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
B. Neyns et al.
ANNALS OF ONCOLOGY (2009)
Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
A. Diaz Miqueli et al.
BRITISH JOURNAL OF CANCER (2009)
Emerging trends of nanomedicine - an overview
Selvarajan Sandhiya et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells
Barry Jutten et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Designer Therapies for Glioblastoma Multiforme
Sith Sathornsumetee et al.
YEAR IN NEUROLOGY 2008 (2008)
Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2
Tobias Martens et al.
CLINICAL CANCER RESEARCH (2008)
Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging
Peter J. Dickinson et al.
JOURNAL OF NEUROSURGERY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms
John H. Rossmeisl et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Expression of receptor tyrosine kinases VEGFR-1 (FLT-1), VEGFR-2 (KDR), EGFR-1, PDGFRα and c-Met in canine primary brain tumours
P. J. Dickinson et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2006)
Long term responses with cetuximab therapy in glioblastoma multiforme
Cristobal Belda-Iniesta et al.
CANCER BIOLOGY & THERAPY (2006)
Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer
Mohamed Hebbar et al.
ANTI-CANCER DRUGS (2006)
Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) - phase I/II trial: study protocol
Stephanie E. Combs et al.
BMC CANCER (2006)
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry
KY Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo
JL Eller et al.
NEUROSURGERY (2005)
The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: A review of preclinical and correlative clinical data
A Chakravarti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results
M Baumann et al.
RADIOTHERAPY AND ONCOLOGY (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas
G Stoica et al.
VETERINARY PATHOLOGY (2004)
Glioblastoma multiforme: Clinical findings, magnetic resonance imaging, and pathology in five dogs
D Lipsitz et al.
VETERINARY PATHOLOGY (2003)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs
IF Dunn et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
